NCT06916260Recruiting
Light Therapy Intervention in Individuals With Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 8 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The study looks to investigate the effects that light therapy delivered to the frontal cortex could have on Parkinson's disease related symptoms ( both cognitive and motor). The therapy is a non invasive technique that deliverers low level wavelength light to the front part of the head for 12 minutes. for this study the therapy will be done 3 times a week for 6 weeks. To measure the potential effects on the therapy in Parkinson symptoms, we will do a set of cognitive and motor test before and after the intervention to measure any changes as well as control for any potential markers such as age, sex, disease level, medication and exercise.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 25 Mar 2025
- Start date
- 4 Apr 2025
- Primary completion date
- 29 Jan 2026
- Lead sponsor
- University of Delaware
- Diseases
- Parkinson disease
- NCT number
- NCT06916260
What you commit to
- Study type: Interventional
- Planned participants: 20
- From 4 Apr 2025 to the primary completion date, 29 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participants who are unable to comply with study visit/testing requirements (e.g.
- participants who cannot go off PD medication for the pre-, post-, and 3-month assessments).
- Participants with PD who have other concurrent movement/neurological conditions, including dystonia, dementia, epilepsy etc.
Other illness
- Participants who have a history of a psychiatric disorder
- Participants with a history of cancer (whether treated with chemotherapy and/or radiotherapy or not).
- Participants with a history of a recent concussion or any facial, neck, or head injury within the last 6 months. UD IRB Approved: 03/12/2025 IRBNet ID#: 2277769-2 I/C from Rev. 01/2024 Page 3 of 10 Participant's Initial's \_\_\_\_\_\_\_\_
- Known injury or disease that might interfere with motor function in the proposed experiments (e.g., stroke, traumatic brain injury, extrapyramidal dysfunction, neuromuscular disease, orthopedic problems that impair movement).
- Participants with a history of photosensitivity.
Other
- Participants who are unable to provide consent.
- Participants with a Deep Brain Stimulation (DBS) device.
- Participants with a clinical diagnosis of PD that is not considered primary (e.g.
- vascular parkinsonism) or participants where an atypical form of parkinsonism is suspected (e.g., progressive supranuclear palsy, multiple system atrophy).
- Participants who are not able to walk unassisted for 2 minutes
Who the study is looking for
- Diagnosis of Parkinson disease
Age in the registry: 50 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Delaware STAR Tower Coordinator of this site? Confirm its status | Newark | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.